In May 2024, the Australasian Dermatology Registry team attended the Australasian College of Dermatologists Annual Scientific Meeting (ACD ASM). Their presence was marked by a dynamic booth that served as a hub for engagement with dermatologists, facilitating the enrolment of new clinics and offering comprehensive training on the online registry platform.
The ACD ASM provided a vital platform for the Australasian Dermatology Registry team to interact directly with dermatologists from across the region. The booth not only attracted attention but also fostered meaningful discussions on the importance of data collection and registry participation in advancing dermatological care. Dermatologists were able to explore the functionalities of the online registry platform firsthand, gaining insights into how it could enhance patient care.
Central to the team’s objectives at the conference was the expansion of their registry network. By actively enrolling new clinics, they aimed to broaden the reach and impact of their data collection efforts. The registry platform not only serves as a repository for clinical data but also facilitates collaboration and knowledge sharing among healthcare professionals. This collaborative approach is crucial for developing comprehensive treatment strategies and improving outcomes for patients with various dermatological conditions.
A highlight of the Australasian Dermatology Registry’s participation was their poster presentation on Hidradenitis Suppurativa (HS). This chronic inflammatory skin condition poses significant challenges for both patients and dermatologists alike. Through the dedicated HS module within the registry, the team showcased their ongoing efforts to compile and analyse data specific to this condition. The poster not only summarised their findings but also underscored the registry’s role in advancing research and understanding of HS within the Australasian context.
The feedback from dermatologists regarding the HS module was overwhelmingly positive. Many expressed interest in contributing data from their own clinics, recognising the potential impact of collective data in refining treatment protocols and improving patient outcomes. The registry’s ability to provide real-time updates and insights into disease trends was particularly noted as a valuable resource for clinical decision-making.